Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
about
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor MicroenvironmentIdentification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.Phase I dendritic cell p53 peptide vaccine for head and neck cancer.T cell-tumor interaction directs the development of immunotherapies in head and neck cancer.Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patientsNew perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.Checkpoint immunotherapy in head and neck cancers.
P2860
Q28071935-29C9B652-1838-4CB7-9128-A06CCE1E45E1Q30436422-CA59CF2C-F044-4F52-B663-43FDFAE46CEDQ30577847-3B660978-95C6-4834-AABD-1D52DA42AA4EQ34475726-49344E94-B995-4555-BCB4-D5FCABBEF502Q35677112-93C7AF6F-B20C-46B6-BD38-C2705B0574CFQ37002959-DE3B3895-A0AF-498D-9B32-9DC9F33810A9Q38389967-6236B9FF-AF32-4D20-8CCE-79FEEB6FCF33Q38810264-550CFD06-8CEF-4422-99A5-92B7C31699F1Q41237376-82CE9A60-C907-4429-B955-2CA768598816Q53098427-4BE6F85F-6456-446B-8B90-308566CD4857
P2860
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@en
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@nl
type
label
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@en
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@nl
prefLabel
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@en
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@nl
P2860
P1476
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
@en
P2093
Albert B DeLeo
Theresa L Whiteside
P2860
P304
P356
10.1586/14760584.7.7.1031
P577
2008-09-01T00:00:00Z